− Cardiovascular Magnetic Resonance (CMR) and Echocardiographic Analyses Demonstrate that Treatment with Vutrisiran Resulted in Significant Changes on Multiple Functional and Structural Cardiac ...

A special technique produces very wide loop BWs in high-frequency PLLs (and hence, indirect (PLL) synthesizers), thereby achieving very low phase noise rivaling that of direct (MMD) synthesizers. A ...

A ceasefire between Israel and Hamas went into effect on Friday. President Donald Trump announced Wednesday that both Israel and Hamas had "signed off" on the first phase of a peace plan in Gaza ...

Biotech firm aTyr Pharma Inc. (NASDAQ:ATYR) plummeted over 81% at last check on Monday, with a session volume of 34.7 million compared to the average volume of 4.83 million as per data from Benzinga ...

Cagrilintide and semaglutide have each been shown to induce weight loss as monotherapies. Data are needed on the coadministration of cagrilintide and semaglutide (called CagriSema) for weight ...

Struggling with SLYCOT installation? control with SLYCOT requires Fortran compilers and BLAS libraries, making it difficult to install across different platforms ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...

Sanofi SA (NASDAQ:SNY) on Tuesday shared progress from its mid- to late-stage respiratory pipeline. The French drug maker reported preliminary results from the TIDE-Asthma phase 2 study of amlitelimab ...

Sustained benefit demonstrated with elevated expression of alpha-galactosidase A (α-Gal A) activity maintained for nearly four years for the longest treated patient as of the data cutoff date Positive ...

RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced updated data from the Phase 1/2 STAAR study evaluating isaralgagene ...